Accelerant Holdings (ARX)
| Market Cap | 3.48B |
| Revenue (ttm) | 953.90M +57.5% |
| Net Income | -1.44B |
| EPS | -7.04 |
| Shares Out | 218.20M |
| PE Ratio | n/a |
| Forward PE | 20.63 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,102,345 |
| Open | 16.22 |
| Previous Close | 16.27 |
| Day's Range | 15.92 - 16.44 |
| 52-Week Range | 9.18 - 31.18 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 19.06 (+19.5%) |
| Earnings Date | May 13, 2026 |
About ARX
Accelerant Holdings, together with its subsidiaries, operates a data-driven risk exchange that connects selected specialty insurance underwriters with risk capital partners. It operates through Exchange Services, MGA Operations, and Underwriting segments. The Exchange Services segment consists of risk exchange, its operating platform that incorporates various technology, data ingestion, and agency operations that serve the needs of its members and risk capital partners. Its Risk capital partners write premiums directly through the Risk Exchange... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 10 analysts, the average rating for ARX stock is "Buy." The 12-month stock price target is $19.06, which is an increase of 19.50% from the latest price.
News
Accelerant to Present at William Blair's 46th Annual Growth Stock Conference
ATLANTA--(BUSINESS WIRE)--Accelerant (NYSE: ARX), the data-driven risk exchange platform transforming the specialty insurance marketplace through the Accelerant Risk Exchange, today announced Jeff Rad...
Accelerant price target raised to $19 from $18 at Piper Sandler
Piper Sandler raised the firm’s price target on Accelerant (ARX) to $19 from $18 and keeps an Overweight rating on the shares. The firm cites recent stock performance and the…
Accelerant price target raised to $16 from $15 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Accelerant (ARX) to $16 from $15 and keeps an Equal Weight rating on the shares. Most property and casualty insurance companies saw…
Accelerant price target raised to $18 from $13 at Piper Sandler
Piper Sandler raised the firm’s price target on Accelerant (ARX) to $18 from $13 and keeps an Overweight rating on the shares following quarterly results. The release was constructive on…
Accelerant Q1 Earnings Call Highlights
Accelerant NYSE: ARX reported stronger-than-expected first-quarter 2026 results, with management pointing to continued growth in its specialty insurance platform, expanding third-party insurer partici...
Accelerant Holdings Earnings Call Transcript: Q1 2026
Q1 2026 saw robust growth in revenue, adjusted EBITDA, and exchange written premium, with strong MGA member additions and high net revenue retention. Guidance for 2026 was raised, reflecting confidence in continued growth and profitability.
Accelerant Holdings Quarterly report: Q1 2026
Accelerant Holdings has published its Q1 2026 quarterly earnings report on May 14, 2026.
Accelerant Holdings Slides: Q1 2026
Accelerant Holdings has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 14, 2026.
Accelerant Holdings Earnings release: Q1 2026
Accelerant Holdings released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.
Accelerant Announces First Quarter 2026 Results
ATLANTA--(BUSINESS WIRE)--Accelerant Holdings (NYSE: ARX) announced financial results for the first quarter ended March 31, 2026.
Accelerant Announces Date of First Quarter 2026 Financial Results and Conference Call
ATLANTA--(BUSINESS WIRE)--Accelerant Holdings (NYSE: ARX), the data-driven risk exchange platform transforming the specialty insurance marketplace through the Accelerant Risk Exchange, today announced...
Unbuzzd Wellness Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant
Vancouver, British Columbia--(Newsfile Corp. - April 22, 2026) - Unbuzzd Wellness Inc. (the "Company" or "Unbuzzd"), the company behind unbuzzdTM ("unbuzzd") — the scientifically-proven and game-chang...
Accelerant price target lowered to $17 from $20 at Citizens
Citizens analyst Matthew Carletti lowered the firm’s price target on Accelerant (ARX) to $17 from $20 and keeps an Outperform rating on the shares. The firm expects Q1 results to…
Accelerant price target raised to $30 from $28 at BMO Capital
BMO Capital analyst Randy Ollenberger raised the firm’s price target on Accelerant (ARX) to $30 from $28 and keeps an Outperform rating on the shares as part of a broader…
Accelerant price target lowered to $15 from $16 at Morgan Stanley
Morgan Stanley analyst Bob Huang lowered the firm’s price target on Accelerant (ARX) to $15 from $16 and keeps an Equal Weight rating on the shares. The firm adjusted target…
Accelerant Completes CFO Transition
ATLANTA--(BUSINESS WIRE)--Accelerant appointed Linda S. Huber as Chief Financial Officer following the previously announced CFO transition.
Accelerant Holdings Proxy statement: Proxy filing
Accelerant Holdings filed a proxy statement on March 30, 2026, providing details for shareholder voting and corporate governance matters.
Accelerant Holdings Proxy statement: Proxy filing
Accelerant Holdings filed a proxy statement on March 30, 2026, providing details for shareholder voting and corporate governance matters.
Accelerant price target lowered to $30 from $36 at TD Cowen
TD Cowen lowered the firm’s price target on Accelerant (ARX) to $30 from $36 and keeps a Buy rating on the shares. The firm updated its model following Q4 results.
Accelerant price target lowered to $16 from $17 at Morgan Stanley
Morgan Stanley lowered the firm’s price target on Accelerant (ARX) to $16 from $17 and keeps an Equal Weight rating on the shares. The firm updated its model to incorporate…
Accelerant price target lowered to $16.50 from $22.50 at BMO Capital
BMO Capital analyst Michael Zaremski lowered the firm’s price target on Accelerant (ARX) to $16.50 from $22.50 and keeps an Outperform rating on the shares. The firm cites lower benchmark…
Accelerant upgraded to Overweight from Equal Weight at Wells Fargo
Wells Fargo upgraded Accelerant (ARX) to Overweight from Equal Weight with a price target of $15, down from $17. The stock fell on what was a good quarter and outlook…
Accelerant Holdings Earnings Call Transcript: Q4 2025
Q4 and full-year 2025 results exceeded expectations, with strong premium growth, expanding margins, and robust free cash flow. AI-driven underwriting and a growing member base support continued outperformance, while guidance for 2026 points to further growth and a shift toward fee-based revenue.
Accelerant Holdings Annual report: Q4 2025
Accelerant Holdings has published its Q4 2025 annual report on March 19, 2026.